Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.
Cardiology August 5th 2024
The Medical Futurist
Non-invasive digital health tools, including wearable sensors and tremor-suppressing devices, are emerging as valuable adjuncts to traditional treatments for tremor management, significantly enhancing patient autonomy and quality of life.
Internal Medicine May 28th 2024
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS